Compugen Ltd At ESMO 2022 Immuno-Oncology Annual Congress Transcript
Ladies and gentlemen, thank you for joining us today. Welcome to the Compugen Investor Conference Call, ESMO Immuno-Oncology. (Operator Instructions) An audio webcast of this call is available in the Investors section of Compugen's website, www.cgen.com. As a reminder, today's call is being recorded.
I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communications.
Thank you, Miguel, and thank you all for joining us on the call today. Joining me from Compugen with the prepared remarks are Dr. Anat Cohen-Dayag, President and Chief Executive Officer; and Dr. Henry Adewoye, Chief Medical Officer. We are also delighted to be joined by Dr. Oladapo Yeku, Assistant Professor of Medicine, Harvard Medical School, and Director of Translational Research, Gynecologic Oncology Program, Massachusetts General Hospital, Boston, who was an investigator on both our dual and triple combination
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
